Skip to main content

Weight Gain After Breast Cancer Development Tied to Heart Failure Risk

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 10, 2025.

via HealthDay

FRIDAY, Jan. 10, 2025 -- For women with newly diagnosed invasive breast cancer (BC), weight gain is associated with an increased risk for heart failure, according to a research letter published online Jan. 9 in JAMA Oncology.

Wonyoung Jung, M.D., Ph.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues examined the association between weight changes and heart failure risk after BC development using the National Health Insurance Service database of the Republic of Korea. The cohort included 43,717 women newly diagnosed with invasive BC without prior heart failure before or within one year of diagnosis. Weight change was assessed from screenings before (zero to two years) and after (0.5 to 2.5 years) BC diagnosis and was classified based on percentage changes.

The researchers found that 6.1, 15.7, 63.9, 10.7, and 3.5 percent of patients had more than 10 percent weight loss, had 5 to 10 percent weight loss, maintained weight, had 5 to 10 percent weight gain, and had more than 10 percent weight gain, respectively. After adjusting for cardiovascular risk factors, cancer treatment, and sociodemographic factors, 5 to 10 percent weight gain was associated with an increased risk for heart failure (adjusted hazard ratio, 1.59) and more than 10 percent weight gain was associated with further increased risk (adjusted hazard ratio, 1.85) compared with weight maintainers during a mean follow-up of 4.67 years. There was no association seen for weight loss with heart failure risk.

"The findings underscore the importance of effective weight intervention in the oncological care of patients with BC, particularly within the first few years after diagnosis, to protect cardiovascular health," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Empagliflozin Has Kidney Protective Effects in Acute Myocardial Infarction

THURSDAY, June 26, 2025 -- Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial...

ADA: Weight Loss, Type 2 Diabetes Remission Up With Replacing Diet Drinks With Water

WEDNESDAY, June 25, 2025 -- For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated with greater weight loss...

BRCA Mutations Linked to Breast Implant Anaplastic Large Cell Lymphoma

WEDNESDAY, June 25, 2025 -- For women with breast cancer (BC), BRCA mutations are associated with increased risk of developing breast implant–associated anaplastic large...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.